CLINICAL SUPPLY MANUFACTURING ARTICLES

Logistics-transportation-GettyImages-1384980908 Vendor/Supplier Management To Maintain A Drug's Safety Profile In End-To-End Supply Chain Planning

FDA 21 CFR 211 requires vendor qualification as a part of the validation process and EU GxP requirements expect robust vendor management, and we expect regulators to issue firmer guidance sooner rather than later. Don't let your pharma/biotech fall short.

CLINICAL SUPPLY MANUFACTURING VIDEOS

Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.

Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.

Susan Dexter, Chief Technical Officer, Sonnet BioTherapeutics, describes the good choices she made, and one not-so-good choice, in trying to untie a knotted supply chain.

Scale your biologic fill-finish from vials to autoinjectors without disruption. See how integrated device assembly capabilities support every clinical phase through commercialization.

CLINICAL SUPPLY MANUFACTURING RESOURCES